Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Femara 2.5mg Tablets | 100-Count | LETROZOLE
Performance & Hormone OptimizationPharma

Femara 2.5mg Tablets | 100-Count | LETROZOLE

$160

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse LETROZOLE — 2.5mg per tablet, 100-count pack. Third-generation aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. Off-label: ovulation induction in PCOS, male hypogonadism from hyperestrogenism. Key warning: Not for premenopausal women without ovarian suppression. Bone density monitoring required — bisphosphonate may be needed. Contraindicated in pregnancy.

SKU
VES-006239-FEMARA-25MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Femara 2.5mg (LETROZOLE)?

Third-generation aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. Off-label: ovulation induction in PCOS, male hypogonadism from hyperestrogenism.

How it Works

Non-steroidal competitive aromatase inhibitor — more potent than anastrozole. Reduces estrogen by over 99% in postmenopausal women.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
LETROZOLE
Dose per Tablet
2.5MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Arthralgia/myalgia (very common — major cause of discontinuation), hot flushes, bone loss/fractures, fatigue, headache, hypercholesterolemia.

Safety Warnings

Not for premenopausal women without ovarian suppression. Bone density monitoring required — bisphosphonate may be needed. Contraindicated in pregnancy. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.